ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancerEmma O’Dowd, David Baldwin, Jürgen Biederer et al.|European Respiratory Journal|2023Cited by 44
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer GroupMariana Brandão, Torsten Blum, Elena Prisciandaro et al.|Lung Cancer|2025Cited by 10